Two sisters with a Charcot-Marie-Tooth disease type 1A (CMT1A) duplication, who had an unusual CMT1A clinical phenotype, are described. The 63-year-old proband presented with dysesthesia on the inner side of the right leg. Neurological examination revealed a localized sensory disturbance in the lowe
Expression profiling of sciatic nerve in a Charcot-Marie-Tooth disease type 1a mouse model
✍ Scribed by Anneloor L.M.A. ten Asbroek; Camiel Verhamme; Marjon van Groenigen; Ruud Wolterman; Maryla M. de Kok-Nazaruk; Frank Baas
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 303 KB
- Volume
- 79
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Expression profiling was performed on sciatic nerve of normal mice and of transgenic mice overexpressing the peripheral myelin protein 22 kDa (PMP22). These mice represent a model for the hereditary peripheral neuropathy Charcot‐Marie Tooth type 1A. Comparison of the profiles reveals that the proteasomal degradation pathway and various signaling mechanisms are up‐regulated in the diseased nerve. The down‐regulated processes represent cell shape and adhesion as well as cellular activity and metabolism. In addition, we found that the most significantly up‐regulated differences could not be mapped on known transcripts and thus might represent not identified transcripts. Our data will be helpful to direct future research aimed at deciphering the molecular pathogenesis of the most prevalent hereditary peripheral neuropathy. © 2005 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## BACKGROUND. A general predisposition for vincristine-related neuropathy has been observed in persons with a family history of hereditary neuropathies. ## METHODS. In a retrospective case series, we investigated the possible association between the DNA rearrangement found in patients with Cha
Genetic heterogeneity within the most common genetic neuropathy, Charcot-Marie-Tooth disease (CMT) results in about 70% slow nerve conduction CMTl and 30% normal nerve conduction CMT2. Autosomal dominant CMTlA on chromosome 17~11.2 represents about 70% of CMTl cases and about 50% of al1 CMT cases. T
Concurrence of myasthenia gravis (MG) and Charcot-Marie-Tooth type 1 (CMT1A) neuropathy is rare. We describe a 60-year-old woman with MG and genetically proved CMT1A. The fluctuating ocular symptoms and proximal limb weakness were markedly improved by pyridostigmine treatment. Recognition of the pos